A Registered Cohort Study of Immune-Mediated Neuropathies

First Affiliated Hospital of Fujian Medical University1,000 enrolled

Overview

This study will provide further insights into the natural course of the disease about Immune-Mediated Neuropathies including clinical features，progression, related antibody spectrum and drug treatment effect.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Chronic Inflammatory Demyelinating Polyneuropathy

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: \- 1. Outpatient or inpatient 2. Meet the diagnostic criteria of various inflammatory peripheral neuropathy. 3. Voluntary participation and informed consent signed by the applicant or his/her family. 4\. Age 18 or above Exclusion Criteria: 1. Severe complications 2. Poor prognosis (\<1 year survival) 3. Severe mental disorder and inability to cooperate with the examination. 4. Age less than 18

Locations (2)

Beijing Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality, China

RECRUITING

Department of Neurology,First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China

NOT_YET_RECRUITING

Outcomes

Primary Outcomes

The correlation between clinical phenotypes and Serum antibodies

Different clinical subtypes of GBS and CIDP have different course and prognosis.It may be related to different serum antibodies.

Time frame: from date of enrollment until the date of death from any cause,assessed up to 20 years

Central Contacts

Lin Yi, PhD

CONTACT

86-0591-87982772 linyi7811@163.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.